Tanezumab (IGHE) - Research Grade Biosimilar
Product Specifications
Background
Tanezumab has been investigated for the treatment of Osteoarthritis, Knee and Neuralgia, Postherpetic.
Immunogen
Humanized / IGHE [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-nd
NCBI Organism
Homo sapiens
Other Product Names
PF-04383119, RN624
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BS74210-01 50 µL
Phospho-PPP1R12A/PPP1R12B/PPP1R12C-T696 polyclonal antibody
Sign In for Pricing
View Details BS74210-02 100 µL
Phospho-PPP1R12A/PPP1R12B/PPP1R12C-T696 polyclonal antibody
Sign In for Pricing
View Details 
K1833705 3x 1.0 µg
RND3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details